Acute pancreatitis can range from a mild, self-limiting disease that requires no more than supportive care to severe disease with life-threatening complications. Therefore, to provide a framework for clinicians to manage acute pancreatitis and to improve national health care, the Korean Pancreatobiliary Association (KPBA) established the first Korean guideline for the management of acute pancreatitis in 2013. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Taking together the recent dramatic changes of latest knowledge and evidence newly obtained, the committee of the KPBA decided to perform an extensive revision of the guidelines. These revised guidelines were developed by using mainly Delphi methods, and the main topics of these guidelines fall under the following topics: 1) diagnosis, 2) severity assessment, 3) initial treatment, nutritional support, and convalescent treatment, 4) the treatment of local complication and necrotizing pancreatitis. The specific recommendations are presented with the quality of evidence and classification of recommendations.

서 론
본 론
    1. 임상진료지침 개정 취지와 목적
    2. 임상진료지침을 적용할 대상 집단 및 임상진료지침이용자
    3. 임상진료지침의 개정 과정 및 내용
    4. 근거수준과 권고등급의 분류
요 약
REFERENCES

• 최정완(고려대학교 의과대학 내과학교실) | Jung Wan Choe (Department of Internal Medicine, Korea University College of Medicine, Seoul)
• 이상협(서울대학교 의과대학 내과학교실 및 간연구소) | Sang Hyub Lee (Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul)
• 천영국(건국대학교 의학전문대학원 내과학교실) | Young Koog Cheon (Department of Internal Medicine, Konkuk University School of Medicine, Seoul)
• 이홍식(고려대학교 의과대학 내과학교실) | Hong Sik Lee (Department of Internal Medicine, Korea University College of Medicine, Seoul)
• 최미영(한국보건의료연구원) | Miyoung Choi (National Evidence-based Healthcare Collaborating Agency, Seoul, Korea)